Back to 
Verition Fund Management LLC
Verition Fund Management LLC
ATAI
Showing 0 of 4 quarters
Position history for Verition Fund Management LLC's holdings in ATAI LIFE SCIENCES NV
No. Verition exited its ATAI (Atai Life Sciences) position in Q4 2023. Its Q3 2023 13F listed 44,482 shares worth $57,382. Verition first reported ATAI in Q1 2023 and held it in 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ATAI: UBS Group AG, Adage Capital Partners GP, L.L.C., Morgan Stanley, ARK Investment Management LLC